AU2002334051A1 - Aminoglycoside lipid derivatives for transfection - Google Patents

Aminoglycoside lipid derivatives for transfection

Info

Publication number
AU2002334051A1
AU2002334051A1 AU2002334051A AU2002334051A AU2002334051A1 AU 2002334051 A1 AU2002334051 A1 AU 2002334051A1 AU 2002334051 A AU2002334051 A AU 2002334051A AU 2002334051 A AU2002334051 A AU 2002334051A AU 2002334051 A1 AU2002334051 A1 AU 2002334051A1
Authority
AU
Australia
Prior art keywords
transfection
lipid derivatives
aminoglycoside
aminoglycoside lipid
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002334051A
Other versions
AU2002334051B2 (en
Inventor
Jean-Marie Lehn
Pierre Lehn
Jean-Pierre Vigneron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Aventis Pharma SA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0111199A external-priority patent/FR2829136B1/en
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Aventis Pharma SA filed Critical Centre National de la Recherche Scientifique CNRS
Priority claimed from PCT/FR2002/002959 external-priority patent/WO2003018603A1/en
Publication of AU2002334051A1 publication Critical patent/AU2002334051A1/en
Application granted granted Critical
Publication of AU2002334051B2 publication Critical patent/AU2002334051B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002334051A 2001-08-29 2002-08-29 Aminoglycoside lipid derivatives for transfection Expired AU2002334051B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0111199A FR2829136B1 (en) 2001-08-29 2001-08-29 LIPID DERIVATIVES OF AMINOGLYCOSIDES
FR01/11199 2001-08-29
US33145201P 2001-11-16 2001-11-16
US60/331,452 2001-11-16
PCT/FR2002/002959 WO2003018603A1 (en) 2001-08-29 2002-08-29 Aminoglycoside lipid derivatives for transfection

Publications (2)

Publication Number Publication Date
AU2002334051A1 true AU2002334051A1 (en) 2003-06-05
AU2002334051B2 AU2002334051B2 (en) 2008-05-15

Family

ID=26213158

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002334051A Expired AU2002334051B2 (en) 2001-08-29 2002-08-29 Aminoglycoside lipid derivatives for transfection

Country Status (7)

Country Link
EP (1) EP1430074B1 (en)
JP (1) JP4629333B2 (en)
AT (1) ATE430758T1 (en)
AU (1) AU2002334051B2 (en)
CA (1) CA2458626C (en)
DE (1) DE60232258D1 (en)
WO (1) WO2003018603A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5407862B2 (en) * 2006-10-04 2014-02-05 サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク(セーエヌエールエス) Composition comprising siRNA and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivative and use thereof
US8790664B2 (en) 2008-09-05 2014-07-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Multimodular assembly useful for intracellular delivery
EP3125945B1 (en) 2014-04-01 2019-09-11 Institut National de la Sante et de la Recherche Medicale (INSERM) Capped and uncapped rna molecules and block copolymers for intracellular delivery of rna

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4923696A (en) * 1995-02-10 1996-08-27 Nexstar Pharmaceuticals, Inc. Lipid constructs for cytoplasmic delivery of agents
FR2741066B1 (en) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS
FR2764304B1 (en) * 1997-06-06 1999-07-16 Rhone Poulenc Rorer Sa NEW CLASS OF CATIONIC NUCLEIC ACID TRANSFECTANTS
WO1999012945A2 (en) * 1997-09-08 1999-03-18 Valentis,Inc. Hydrophobic glycosylamine derivatives, compositions, and methods for use
WO2000040692A2 (en) * 1999-01-05 2000-07-13 Valentis, Inc. Methods and compositions for delivering nucleic acids
GB9930533D0 (en) * 1999-12-23 2000-02-16 Mitsubishi Tokyo Pharm Inc Nucleic acid delivery

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001258117A1 (en) Supports for photosensitizer formulations
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001284362A1 (en) Resorcinol derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU4430701A (en) Compounds for targeting
AU2001278694A1 (en) Avermectin derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU1548101A (en) Sphingosine derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2002330717A1 (en) Monosaccharide derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2002333276A1 (en) Drugs for vasculopaties
AU2001262489A1 (en) Triterpenoid derivatives
AU2002334051A1 (en) Aminoglycoside lipid derivatives for transfection
AU2001266915A1 (en) Probes for chondrogenesis
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives
AU2001288484A1 (en) Novel metallotexaphyrin derivatives
AU2002358298A1 (en) Methods for preparing doxorubicin derivatives